Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. (Q53577553)
Jump to navigation
Jump to search
scientific article published on 13 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. |
scientific article published on 13 March 2015 |
Statements
Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. (English)
Joseph F Sobanko
Rosalie Elenitsas
Jason G Newman
Hayley Goldbach
Thuzar M Shin
Christopher J Miller
13 March 2015
72
5
840-850